NASDAQ:MEDS Wellgistics Health (MEDS) Stock Price, News & Analysis $2.23 -0.07 (-3.04%) As of 10/23/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About Wellgistics Health Stock (NASDAQ:MEDS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Wellgistics Health alerts:Sign Up Key Stats Today's Range$2.14▼$2.3750-Day Range$0.85▼$6.0752-Week Range$0.82▼$73.00Volume350,387 shsAverage Volume5.86 million shsMarket Capitalization$7.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Wellgistics Health, Inc. is a healthcare technology and pharmaceutical distribution company focused on improving access to prescription medications. The company connects pharmaceutical manufacturers, wholesalers, pharmacies, healthcare providers and patients through technology-enabled services designed to support the movement and dispensing of medications. Its business includes pharmaceutical distribution and related supply-chain solutions, with an emphasis on helping pharmacies and healthcare organizations source and manage prescription products. Wellgistics also develops digital infrastructure intended to streamline ordering, fulfillment, communication and other operational processes across the medication supply chain. The company primarily serves participants in the U.S. healthcare and pharmaceutical markets. Publicly available information about its detailed operating history and leadership is limited, and the company’s services and strategic focus may continue to evolve as it expands its healthcare technology platform.AI Generated. May Contain Errors. Read More Wellgistics Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreMEDS MarketRank™: 0.433234819985 of 5 starsWellgistics Health scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingWellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageWellgistics Health has only been the subject of 1 research reports in the past 90 days.Read more about Wellgistics Health's stock forecast and price target. Earnings and ValuationN/AProj. Earnings GrowthN/A Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted23.16% of the float of Wellgistics Health has been sold short.Short Interest Ratio / Days to CoverWellgistics Health has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Wellgistics Health has recently increased by 21.93%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWellgistics Health does not currently pay a dividend.Dividend GrowthWellgistics Health does not have a long track record of dividend growth. News and Social Media1.6 / 5News SentimentN/A News SentimentWellgistics Health has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Wellgistics Health this week, compared to 2 articles on an average week.Search InterestOnly 8 people have searched for MEDS on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Wellgistics Health insiders have not sold or bought any company stock.Percentage Held by Insiders29.10% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions5.68% of the stock of Wellgistics Health is held by institutions.Read more about Wellgistics Health's insider trading history. Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Wellgistics Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MEDS Stock News HeadlinesDataMeds AI (NASDAQ: MEDS) says it clears Nasdaq equity floor with REBOOT pactOctober 20, 2026 | americanbankingnews.comDataMeds AI’s Corexa Pharmacy Surpasses $1 Million In Monthly RevenueOctober 1, 2026 | insidermonkey.comWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare. | Digest Publishing (Ad)DataMeds AI and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National CampaignSeptember 8, 2026 | markets.businessinsider.comDataMeds, Tollo Health Partner NFL Alumni for Rural Health AccessSeptember 8, 2026 | usatoday.comDataMEDS AI Officially Begins Trading Under Stock Symbol ‘MEDS’ on the NASDAQ Capital MarketsJuly 22, 2026 | usatoday.comWELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.July 21, 2026 | prnewswire.comWellgistics Health, Inc.: Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to StockholdersJuly 20, 2026 | finanznachrichten.deSee More Headlines MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed this year? Wellgistics Health's stock was trading at $20.00 at the beginning of 2026. Since then, MEDS stock has decreased by 88.9% and is now trading at $2.23. How were Wellgistics Health's earnings last quarter? Wellgistics Health, Inc. (NASDAQ:MEDS) issued its earnings results on Monday, August, 17th. The company reported ($7.13) EPS for the quarter. The company had revenue of $1.78 million for the quarter. When did Wellgistics Health's stock split? Wellgistics Health shares reverse split before market open on Tuesday, May 26th 2026.The 1-50 reverse split was announced on Wednesday, May 20th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Wellgistics Health? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/17/2026Today10/24/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, MEDS's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Distributors Current SymbolNASDAQ:MEDS Previous SymbolNASDAQ:WGRX CIK2030763 Webwww.wellgisticshealth.com Phone1-843-302-1785FaxN/AEmployees31Year FoundedN/AProfitability EPS (Trailing Twelve Months)($46.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$101.28 million Net Margins-1,100.16% Pretax Margin-1,100.17% Return on EquityN/A Return on Assets-171.81% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.10 Sales & Book Value Annual Sales$23.34 million Price / Sales0.31 Cash FlowN/A Price / Cash FlowN/A Book Value($6.94) per share Price / Book-0.32Miscellaneous Outstanding Shares3,200,000Free Float2,267,000Market Cap$7.14 million OptionableN/A Beta-3.51 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:MEDS) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wellgistics Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wellgistics Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
